3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease
- PMID: 16300642
- DOI: 10.1111/j.1471-4159.2005.03515.x
3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease
Abstract
Huntington's disease (HD) is a neurodegenerative disorder caused by a mutation in the gene encoding Huntingtin. The mechanisms underlying the preferential degeneration of the striatum, the most striking neuropathological change in HD, are unknown. Of those probably involved, mitochondrial defects might play an important role. The behavioural and anatomical similarities found between HD and models using the mitochondrial toxin 3-nitropropionic acid (3NP) in rats and primates support this hypothesis. Here, we discuss the recently identified mechanisms of 3NP-induced striatal degeneration. Two types of important factor have been identified. The first are the 'executioner' components that have direct roles in cell death, such as c-Jun N-terminal kinase and Ca2+-activated protease calpains. The second are 'environmental' factors, such as glutamate, dopamine and adenosine, which modulate the striatal degeneration induced by 3NP. Interestingly, these recent studies support the hypothesis that 3NP and mutated Huntingtin have certain mechanisms of toxicity in common, suggesting that the use of 3NP might give new insights into the pathogenesis of HD. Research on 3NP provides additional proof that the neurochemical environment of a given neurone can determine its preferential vulnerability in neurodegenerative diseases.
Similar articles
-
Death of cortical and striatal neurons induced by mitochondrial defect involves differential molecular mechanisms.Neurobiol Dis. 2004 Feb;15(1):152-9. doi: 10.1016/j.nbd.2003.09.013. Neurobiol Dis. 2004. PMID: 14751780
-
Astrocytes from cortex and striatum show differential responses to mitochondrial toxin and BDNF: implications for protection of striatal neurons expressing mutant huntingtin.J Neuroinflammation. 2020 Oct 6;17(1):290. doi: 10.1186/s12974-020-01965-4. J Neuroinflammation. 2020. PMID: 33023623 Free PMC article.
-
Memantine reduces striatal cell death with decreasing calpain level in 3-nitropropionic model of Huntington's disease.Brain Res. 2006 Nov 6;1118(1):199-207. doi: 10.1016/j.brainres.2006.08.035. Epub 2006 Sep 7. Brain Res. 2006. PMID: 16959224
-
Mitochondria in Huntington's disease.Biochim Biophys Acta. 2010 Jan;1802(1):52-61. doi: 10.1016/j.bbadis.2009.07.012. Epub 2009 Aug 11. Biochim Biophys Acta. 2010. PMID: 19682570 Review.
-
Replicating Huntington's disease phenotype in experimental animals.Prog Neurobiol. 1999 Dec;59(5):427-68. doi: 10.1016/s0301-0082(99)00005-2. Prog Neurobiol. 1999. PMID: 10515664 Review.
Cited by
-
Mediators of mitophagy that regulate mitochondrial quality control play crucial role in diverse pathophysiology.Cell Biol Toxicol. 2021 Jun;37(3):333-366. doi: 10.1007/s10565-020-09561-1. Epub 2020 Oct 17. Cell Biol Toxicol. 2021. PMID: 33067701 Review.
-
The role of mitochondrial dysfunction in age-related diseases.Biochim Biophys Acta. 2015 Nov;1847(11):1387-400. doi: 10.1016/j.bbabio.2015.05.021. Epub 2015 Jun 4. Biochim Biophys Acta. 2015. PMID: 26050974 Free PMC article. Review.
-
Optimal dosages of fluoxetine in the treatment of hypoxic brain injury induced by 3-nitropropionic acid: implications for the adjunctive treatment of patients after acute ischemic stroke.CNS Neurosci Ther. 2012 Jul;18(7):530-5. doi: 10.1111/j.1755-5949.2012.00315.x. Epub 2012 Apr 19. CNS Neurosci Ther. 2012. PMID: 22515819 Free PMC article.
-
Melatonin ameliorates injury and specific responses of ischemic striatal neurons in rats.J Histochem Cytochem. 2013 Aug;61(8):591-605. doi: 10.1369/0022155413492159. Epub 2013 May 16. J Histochem Cytochem. 2013. PMID: 23686363 Free PMC article.
-
Metal dyshomeostasis and inflammation in Alzheimer's and Parkinson's diseases: possible impact of environmental exposures.Oxid Med Cell Longev. 2013;2013:726954. doi: 10.1155/2013/726954. Epub 2013 Apr 17. Oxid Med Cell Longev. 2013. PMID: 23710288 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous